key: cord-1007098-lqds6bzj
authors: Binder, Raquel A; Alarja, Natalie A; Robie, Emily R; Kochek, Kara E; Xiu, Leshan; Rocha-Melogno, Lucas; Abdelgadir, Anfal; Goli, Sumana V; Farrell, Amanda S; Coleman, Kristen K; Turner, Abigail L; Lautredou, Cassandra C; Lednicky, John A; Lee, Mark J; Polage, Christopher R; Simmons, Ryan A; Deshusses, Marc A; Anderson, Benjamin D; Gray, Gregory C
title: Environmental and Aerosolized SARS-CoV-2 Among Hospitalized COVID-19 Patients
date: 2020-09-09
journal: J Infect Dis
DOI: 10.1093/infdis/jiaa575
sha: 383b88f98cd7a44c98991793ac1f4e2258c86667
doc_id: 1007098
cord_uid: lqds6bzj

During April and May 2020, we studied 20 hospitalized COVID-19 patients, their hospital rooms (fomites and aerosols), and their close contacts for molecular and culture evidence of SARS-CoV-2 virus. Among the more than 400 samples, we found molecular evidence of virus in most sample types, especially the nasopharygeal (NP), saliva, and fecal samples, but the prevalence of molecular positivity among fomites and aerosols was low. The agreement between NP swab and saliva positivity was high (89.5%, Kappa 0.79). Two NP swabs collected from patients on one and seven days post-symptom onset had evidence of infectious virus (2 passages over 14 days in Vero E6 cells). In summary, the low molecular prevalence and lack of viable SARS-CoV-2 virus in fomites and air samples implied low nosocomial risk SARS-CoV-2 transmission through inanimate objects or aerosols.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe since its likely origins in China during late 2019. 1 Many infection control and physical distancing efforts have been employed to stem this transmission. 1 SARS-CoV-2 transmission by fomites has been assumed, based on experimental and observational studies, alongside assumptions that SARS-CoV-2 behaves similarly to other respiratory viruses. [2] [3] [4] [5] Similarly, an existing body of observational coronavirus disease 2019 (COVID-19) studies and related experimental research work suggests that SARS-CoV-2 is transmitted by aerosols and may travel greater distances than two meters, similar to SARS-CoV-1 in 2003/04. [6] [7] [8] [9] [10] [11] Further, fecal-oral transmission has been deemed possible as well. 12 However, more information is needed to clearly define the above mentioned transmission pathways, particularly in clinical settings where the protection of health care professionals is critical while personal protective gear is in shortage.

Towards this end, we collected, screened and cultured biological, environmental and aerosol samples from hospitalized COVID-19 patients and their close contacts.

This study was approved by Duke University IRB (Protocol 00105055).

Between April 10 th and May 22 nd , 2020, hospitalized patients at Duke University Hospital (DUH) with either a positive SARS-CoV-2 molecular test or COVID-19 symptomatology (n=20) were invited to participate in the study ( Figure S1 ). Close contacts of COVID-19 patients were also encouraged to participate. patients and close contacts were asked to permit the collection of a A c c e p t e d M a n u s c r i p t 5 nasopharyngeal (NP) swab, complete a brief questionnaire and to provide a saliva and a self-collected rectal swab sample. The same biological samples and a brief symptom questionnaire were again collected 14 and 28 days post-enrollment from COVID-19 patients, and 21 days post-enrollment from their close contacts.

Environmental swabs and aerosol samples were collected in COVID-19 patient rooms.

The COVID-19 patient rooms sampled during this study were all single occupant rooms without a connected bathroom or toilet. Instead, in-room portable toilets (commodes) were available for patients (S2). Measurements performed in a representative empty DUH patient room on the COVID-19 ward determined that air inside the room was exchanged ~14 times every hour. This is higher than the hours. 13 Per our previous publications, [14] [15] [16] NIOSH samplers were calibrated to a flow-rate of 3.5 L air /min before the sampling event, each sampling approximately 840 L air during the 4 hours. The selected flow-rate represents typical human inhalation rates, ranging between 3-13 L air /min during rest or light intensity activities. 17 The NIOSH samplers separated particles by three sizes: >4 µm, 1-4 µm, and <1 µm in 15 mL tubes, 1.5 mL centrifuge tubes, and polytetrafluoroethylene (PTFE) filters, respectively ( Figure S3 ).

Detailed descriptions of the molecular and viral culture methods are provided in the supplementary appendix. Briefly, NP swabs were collected with BD™ Universal Viral Transport Standard Kits (BD, Franklin Lakes, NJ) containing a 3 mL VTM vial with scored and spun sterile regular polyester-tipped plastic swabs using standard clinical procedures. Study participants were asked to collect ~2 mL passive drool into a 50 mL conical tube, which was then diluted 2:1 with PBS (with 0.5% BSA) in order to preserve potential virus contained in the sample and to facilitate further processing. When possible, a self-collected rectal swab was obtained from study subjects by providing either a sterile FLOQSwab® (Copan, Avenue Murrieta, CA) or sterile BD™ swab and 1.5 mL VTM (Redoxica, Little Rock, Arkansas). The A c c e p t e d M a n u s c r i p t 7 following environmental swab samples from patient rooms were collected with prewetted FLOQSwabs® and placed in 1.5 mL VTM: toilet seat and interior of toilet bowl, TV remote control, cell phone, bed railing (left and right) and bed tray ( Figure   S2 ).

Fomite and aerosol sampling was conducted in an empty hospital room (no patient contact for four days) in the DUH COVID-19 ward which had been disinfected by bleach solution wipe downs and UV light treatment for 45 minutes.

We also performed aerosol sampling in the COVID-19 hospital ward hallway with two aerosol samplers outside of an occupied patient room and two samplers outside of an empty hospital room that had been disinfected, both 1.5 meters from the ground. On the same day, environmental swabs from the hospital ward break room and head nurse and physician workstation were collected. 

Among the 20 SARS-CoV-2 hospitalized patients enrolled, 10 (50.0%) were female, eight (40.0%) were Caucasian, eight (40.0%) were African American, three (15.0%) were Hispanic, and one (5.0%) was Native American. Ages ranged from 29 to 91 years, while the median age was 50 years. The majority (n=15, 75.0%) had self-reported pre-existing illnesses such as chronic respiratory conditions A c c e p t e d M a n u s c r i p t 9 (asthma, chronic bronchitis or emphysema), hypertension, diabetes, cancer, or liver disease (Table S1) Tables S2, S3 and S4. Among the environmental swabs taken from the 19 patient rooms, five rooms (26.3%) had one or more positive fomite such as toilet bowl, bed railing (twice), TV remote (twice), bed tray and cell phone (Cts ranged from 36.4 -39.8), see Table 1 and Table S5 (Table 1 and Table S5 ). (Table S5) . Hence, two enrollment NP swabs showed CPE during the second passage ( Figure 2 and 

In contrast to several previously published reports, 4,19-21 we found sparse evidence of SARS-CoV-2 among fomite and aerosol samples collected from COVID-19 patients at the DUH hospital ward, despite relatively high SARS-CoV-2 prevalence among biological samples. Where molecular evidence of virus was detected, the Ct values were high (median 35.3 Ct), suggesting that while specific SARS-CoV-2 nucleic acid was present, the quantities were low. Furthermore, no A c c e p t e d M a n u s c r i p t 13 infectious virus was cultured from fomite or aerosol samples. Importantly, 10 (50.0%) of our study participants were enrolled eight days or more into their illness, a cut point after which others have found it difficult to culture viable virus from patient samples and after which viral shedding may be cleared. 22-25,23,26 . Interestingly, the agreement between NP swab and saliva positivity was high, indicating that passive drool may be a valuable non-invasive sample for SARS-

There has been considerable debate regarding the risk of SARS-CoV-2 transmission through contact with fomites and inhalation of aerosols. 27,28 SARS-CoV-1, genomically almost identical to SARS-CoV-2, 29 is thought to be transmissible through aerosols, 30 and SARS-CoV-2 has been shown to remain viable for up to 16 hours in aerosols, 31 supporting potential airborne transmission.

Interestingly, cats may be infected by aerosolized SARS-CoV-2, 32 but not humanized ACE2 mice. 33 Moreover, observational studies support potential aerosol transmission of SARS-CoV-2, as exemplified by transmission during a choir practice outbreak in Washington 34 and a restaurant in China. 35 Finally, several other studies conducted in clinical settings found high viral RNA positivity in fomite and aerosol samples and evidence of infectious virus has been implied in aerosol samples. 4, 6, [9] [10] [11] 19, 20 In contrast, only three out of 195 (1.5%) aerosol samples had detectable SARS-CoV-2 RNA in our clinical setting, and none showed evidence of viable virus. Similarly, a hospital study conducted in Wuhan, China observed no SARS-CoV-2 RNA in 44 aerosol samples and a strikingly low positivity among fomites (1.3%). 36 

Singapore also failed to detect SARS-CoV-2 RNA in aerosols, 21 although a follow up study later detected it in two COVID-19 patient rooms in the same facility. 6 As M a n u s c r i p t 14 for captured droplet size, the NIOSH sampler has roughly a 95% collection efficiency for aerosols with a diameter of 7 micrometers or less, which decreases to approximately 40% efficiency for aerosols ~80 micrometers in diameter. Hence, smaller aerosolized particles were more likely to be captured by our study as compared to larger ballistic droplets. However, surfaces, likely contaminated by larger droplets near the patient, were sampled via the surface swabbing. The study had a number of limitations. As has been previously documented, viral loads are highest shortly after symptom onset and the median length of time from infection until viral clearance is estimated to be nine days. [22] [23] [24] [25] Hence, it is plausible that a number of the studied COVID-19 patients were not shedding A c c e p t e d M a n u s c r i p t 15 virus as readily as they were early in their disease course. It is also possible that therapeutic interventions may have reduced virus transmission as eight (40.0%) of subjects were co-enrolled in clinical trials. We also acknowledge that we used dry cyclone aerosol samplers, which are not as well-suited for viable virus collection when compared to liquid collection medium-based bioaerosol samplers as exemplified by a study capturing infectious SARS-CoV-2 2 and 4.8 meters from patients with the VIVAS air samplers that operate on a gentle water-vapor condensation principle. 10 Further, while the long bioaerosol sampling time (4 hours) intended to capture the temporal variability of viral emissions from the patients, it may also have decreased the viability of infectious virus. 13 However, we have previously captured viable virus using the NIOSH samplers, albeit in settings with high levels of viral contamination, such as live bird markets in Vietnam and China. 38, 39 We also acknowledge that the study has a relatively small sample size and the patients were not randomly selected. Hence patients may not be 

Coronavirus disease 2019: What we know

Exaggerated risk of transmission of COVID-19 by fomites

Prolonged Infectivity of SARS-CoV-2 in Fomites

Aerosol and Surface Transmission Potential of SARS-CoV-2

Indoor Air and COVID-19 Key References and Publications

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection

Consideration of the Aerosol Transmission for COVID-19 and Public Health

The Infectious Nature of Patient-Generated SARS-CoV-2 Aerosol

Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients

Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care

Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?

Development of an improved methodology to detect infectious airborne influenza virus using the NIOSH bioaerosol sampler

Bioaerosol Sampling for Respiratory Viruses in Singapore's Mass Rapid Transit

Monitoring for airborne respiratory viruses in a general pediatric ward in Singapore

Molecular surveillance of respiratory viruses with bioaerosol sampling in an airport

Exposure Factors Handbook

The CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel

Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London

SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19

Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient

Viral load of SARS-CoV-2 in clinical samples

Duration of Isolation and Precautions for Adults with COVID-19

Determining the period of communicability of SARS-CoV-2: A rapid review of the literature

Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2 Infection (Interim Guidance)

SARS-CoV-2 virus culture from the upper respiratory tract: Correlation with viral load, subgenomic viral RNA and duration of illness

It is Time to Address Airborne Transmission of COVID-19

World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions. Geneva: World Health Organization

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Evidence of airborne transmission of the severe acute respiratory syndrome virus

Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice

High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice -Skagit County

Detection of SARS-CoV-2 in Exhaled Breath from COVID-19 Patients Ready for Hospital Discharge

Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva

Bioaerosol Sampling to Detect Avian Influenza Virus in Hanoi's Largest Live Poultry Market

Bioaerosol Sampling at a Live Animal Market in Kunshan, China: A Noninvasive Approach for Detecting Emergent Viruses

We thank Professor Gregory D. Sempowski, Dr. Thomas Oguin, and Rose Asrican from the Duke Regional Biocontainment Laboratory (